FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Firm Petitions for Adding Chromium to OTC Acne Monograph

[ Price : $8.95]

Metabolic Therapy Inc. petitions FDA to amend the Over-the Counter Acne Drug Products monograph for active ingredients to indicate...

Drug Marketers Digital Efforts Eclipse Traditional Detail Visits

[ Price : $8.95]

Marketing consultant ZS Associates report that drug company digital and non-personal contacts are on the rise as sales representat...

ICH Guidance on Nonclinical Studies for Anticancer Agents

[ Price : $8.95]

FDA posts an International Conference on Harmonization draft guidance on S9 Nonclinical Evaluation for Anticancer Pharmaceuticals...

HHS, NIH Move to Increase Clinical Trial Transparency

[ Price : $8.95]

HHS issues a new rule and the National Institutes of Health issues a new policy, both intended to increase the availability of cli...

FDA Mulls New Clinical Trial Eligibility Criteria: Pazdur

[ Price : $8.95]

FDA Oncology Center of Excellence acting director Richard Pazdur says his Center is working with stakeholders to revisit criteria ...

Comments Sought on Unique Device Identifier Requirements

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on a proposed collection of information related to the agencys Unique Device Identific...

Guidance on Total Kidney Volume Biomarker

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance on Qualification of Biomarker Total Kidney Volume in Studies for Treatment of Au...

Guidance on Gene Therapy Microbial Vector Recommendations

[ Price : $8.95]

Federal Register Notice: FDA posts a guidance on Recommendations for Microbial Vectors Used for Gene Therapy that provides recomme...

Guidance on Animal Drug Bioequivalence Waivers

[ Price : $8.95]

Federal Register Notice: FDA releases a revised guidance for industry (#171) on Waivers from the Requirement to Demonstrate Bioequ...

Workshop on Coordinated Antibiotic, Related Test Development

[ Price : $8.95]

Federal Register Notice: FDA plans a public workshop on Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptib...